标题
Recombinant protein vaccines, a proven approach against coronavirus pandemics
作者
关键词
SARS-CoV-2, COVID-19, Adjuvants, Vaccine production, Vaccine delivery, Clinical trials, Neutralizing antibodies, Th1
出版物
ADVANCED DRUG DELIVERY REVIEWS
Volume 170, Issue -, Pages 71-82
出版商
Elsevier BV
发表日期
2021-01-08
DOI
10.1016/j.addr.2021.01.001
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China
- (2020) Aiping Wu et al. Cell Host & Microbe
- Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2
- (2020) Renhong Yan et al. SCIENCE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- The role of IgA in COVID-19
- (2020) Yin Xia Chao et al. BRAIN BEHAVIOR AND IMMUNITY
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
- (2020) Wanbo Tai et al. Cellular & Molecular Immunology
- Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)
- (2020) Li Guo et al. CLINICAL INFECTIOUS DISEASES
- A recombinant Lactobacillus plantarum strain expressing the spike protein of SARS-CoV-2
- (2020) Maopeng Wang et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Laboratory Diagnosis of COVID-19: Current Issues and Challenges
- (2020) Yi-Wei Tang et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The potential role of Th17 immune responses in coronavirus immunopathology and vaccine-induced immune enhancement
- (2020) Peter J. Hotez et al. MICROBES AND INFECTION
- Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development
- (2020) Eun Kim et al. EBioMedicine
- New GMP manufacturing processes to obtain thermostable HIV-1 gp41 virosomes under solid forms for various mucosal vaccination routes
- (2020) Mario Amacker et al. npj Vaccines
- A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS
- (2020) Lianpan Dai et al. CELL
- SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in ‘lasso’ for the multi-faced virus
- (2020) V. V. Oberemok et al. INFLAMMATION RESEARCH
- SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
- (2020) Giovanni Salvatori et al. Journal of Translational Medicine
- SARS-CoV-2 vaccines: ‘Warp Speed’ needs mind melds not warped minds
- (2020) John P. Moore et al. JOURNAL OF VIROLOGY
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
- (2020) Jingyun Yang et al. NATURE
- Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
- (2020) Lihong Liu et al. NATURE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults
- (2020) Jerald Sadoff et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and Immunogenicity of Heterologous and Homologous Two Dose Regimens of Ad26- and MVA-Vectored Ebola Vaccines: A Randomized, Controlled Phase 1 Study
- (2020) Neil Goldstein et al. JOURNAL OF INFECTIOUS DISEASES
- SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition
- (2020) Annika Nelde et al. NATURE IMMUNOLOGY
- Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
- (2020) Cheryl Keech et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19
- (2020) Tsun-Yung Kuo et al. Scientific Reports
- A Brief Reminder of Systems of Production and Chromatography-Based Recovery of Recombinant Protein Biopharmaceuticals
- (2019) B. Owczarek et al. Biomed Research International
- Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines
- (2019) E. Criscuolo et al. Journal of Immunology Research
- Safety of AS03-adjuvanted influenza vaccines: A review of the evidence
- (2019) Catherine Cohet et al. VACCINE
- Recombinant Proteins for Industrial versus Pharmaceutical Purposes: A Review of Process and Pricing
- (2019) John Puetz et al. Processes
- Randomized controlled trial demonstrating the benefits of delta inulin adjuvanted immunotherapy in patients with bee venom allergy
- (2019) Robert Heddle et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development
- (2019) Nagesh K. Tripathi et al. Frontiers in Bioengineering and Biotechnology
- Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice
- (2018) Sofia E. Magnusson et al. IMMUNOLOGIC RESEARCH
- Immunology and efficacy of MF59-adjuvanted vaccines
- (2018) Eun-Ju Ko et al. Human Vaccines & Immunotherapeutics
- Advax augments B and T cell responses upon influenza vaccination via the respiratory tract and enables complete protection of mice against lethal influenza virus challenge
- (2018) Jasmine Tomar et al. JOURNAL OF CONTROLLED RELEASE
- The Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLT
- (2018) John D. Clements et al. mSphere
- Emerging experience with meningococcal serogroup B protein vaccines
- (2017) Daniela Toneatto et al. Expert Review of Vaccines
- Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
- (2017) Jesper Pallesen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Panblok-H1+advax H1N1/2009pdm vaccine: Insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine
- (2017) Yoshikazu Honda-Okubo et al. Human Vaccines & Immunotherapeutics
- AS03- and MF59-Adjuvanted Influenza Vaccines in Children
- (2017) Amanda L. Wilkins et al. Frontiers in Immunology
- Advax, a Delta Inulin Microparticle, Potentiates In-built Adjuvant Property of Co-administered Vaccines
- (2017) Masayuki Hayashi et al. EBioMedicine
- The novel Lyme borreliosis vaccine VLA15 shows broad protection against Borrelia species expressing six different OspA serotypes
- (2017) Pär Comstedt et al. PLoS One
- Improvement of Pharmacokinetic Profile of TRAIL via Trimer-Tag Enhances its Antitumor Activity in vivo
- (2017) Haipeng Liu et al. Scientific Reports
- Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®)
- (2016) Ashesh Gandhi et al. POSTGRADUATE MEDICINE
- Evaluation of potential immunogenicity differences betweenPandemrix™ andArepanrix™
- (2016) Quentin Canelle et al. Human Vaccines & Immunotherapeutics
- Bivalent rLP2086 Vaccine (Trumenba®): A Review in Active Immunization Against Invasive Meningococcal Group B Disease in Individuals Aged 10–25 Years
- (2015) Matt Shirley et al. BIODRUGS
- Effect of vaccine administration modality on immunogenicity and efficacy
- (2015) Lu Zhang et al. Expert Review of Vaccines
- High titre neutralising antibodies to influenza after oral tablet immunisation: a phase 1, randomised, placebo-controlled trial
- (2015) David Liebowitz et al. LANCET INFECTIOUS DISEASES
- Advax™, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety
- (2015) Nikolai Petrovsky et al. VACCINE
- The novel adjuvant dmLT promotes dose sparing, mucosal immunity and longevity of antibody responses to the inactivated polio vaccine in a murine model
- (2015) Elizabeth B. Norton et al. VACCINE
- Expression, purification, and characterization of theNecator americanusaspartic protease-1 (Na-APR-1 (M74)) antigen, a component of the bivalent human hookworm vaccine
- (2015) Christopher A Seid et al. Human Vaccines & Immunotherapeutics
- New tools for NTD vaccines: A case study of quality control assays for product development of the human hookworm vaccineNa-APR-1M74
- (2015) Mark S Pearson et al. Human Vaccines & Immunotherapeutics
- Advances in aluminum hydroxide-based adjuvant research and its mechanism
- (2015) Peng He et al. Human Vaccines & Immunotherapeutics
- Advax-Adjuvanted Recombinant Protective Antigen Provides Protection against Inhalational Anthrax That Is Further Enhanced by Addition of Murabutide Adjuvant
- (2014) Brandon Feinen et al. Clinical and Vaccine Immunology
- Multiple Low-Dose Challenges in a Rhesus Macaque AIDS Vaccine Trial Result in an Evolving Host Response That Affects Protective Outcome
- (2014) Christian Selinger et al. Clinical and Vaccine Immunology
- The Pathology and Pathogenesis of Experimental Severe Acute Respiratory Syndrome and Influenza in Animal Models
- (2014) J.M.A. van den Brand et al. JOURNAL OF COMPARATIVE PATHOLOGY
- Prior Immunization with Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected with SARS-CoV
- (2014) F. Yasui et al. JOURNAL OF IMMUNOLOGY
- Severe Acute Respiratory Syndrome-Associated Coronavirus Vaccines Formulated with Delta Inulin Adjuvants Provide Enhanced Protection while Ameliorating Lung Eosinophilic Immunopathology
- (2014) Yoshikazu Honda-Okubo et al. JOURNAL OF VIROLOGY
- Design and Development of a Novel Vaccine for Protection against Lyme Borreliosis
- (2014) Pär Comstedt et al. PLoS One
- Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: A randomized controlled Phase 1 study
- (2014) David Gordon et al. VACCINE
- Comparative Evaluation of Recombinant Protein Production in Different Biofactories: The Green Perspective
- (2014) Matilde Merlin et al. Biomed Research International
- Recombinant protein expression in Escherichia coli: advances and challenges
- (2014) Germán L. Rosano et al. Frontiers in Microbiology
- Protein production using the baculovirus-insect cell expression system
- (2013) A. Contreras-Gómez et al. BIOTECHNOLOGY PROGRESS
- Secreted heat shock protein gp96-Ig: next-generation vaccines for cancer and infectious diseases
- (2013) Natasa Strbo et al. IMMUNOLOGIC RESEARCH
- An Inactivated Cell Culture Japanese Encephalitis Vaccine (JE-ADVAX) Formulated with Delta Inulin Adjuvant Provides Robust Heterologous Protection against West Nile Encephalitis via Cross-Protective Memory B Cells and Neutralizing Antibody
- (2013) N. Petrovsky et al. JOURNAL OF VIROLOGY
- Immune enhancing properties of the novel Matrix-M™ adjuvant leads to potentiated immune responses to an influenza vaccine in mice
- (2013) Sofia E. Magnusson et al. VACCINE
- Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate
- (2013) Wen-Hsiang Chen et al. Human Vaccines & Immunotherapeutics
- Correction: Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
- (2012) Chien-Te Tseng et al. PLoS One
- Survey of the prevalence of immunization non-compliance due to needle fears in children and adults
- (2012) Anna Taddio et al. VACCINE
- MF59 adjuvant: the best insurance against influenza strain diversity
- (2011) Derek T O’Hagan et al. Expert Review of Vaccines
- Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial
- (2011) Rebecca J. Cox et al. VACCINE
- An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses
- (2010) Guangyu Zhao et al. Virology Journal
- Tobacco, a highly efficient green bioreactor for production of therapeutic proteins
- (2009) Reynald Tremblay et al. BIOTECHNOLOGY ADVANCES
- Recombinant Ov-ASP-1, a Th1-Biased Protein Adjuvant Derived from the Helminth Onchocerca volvulus, Can Directly Bind and Activate Antigen-Presenting Cells
- (2009) Y. He et al. JOURNAL OF IMMUNOLOGY
- Engineering complex-type N-glycosylation in Pichia pastoris using GlycoSwitch technology
- (2009) Pieter P Jacobs et al. Nature Protocols
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started